https://www.selleckchem.com/products/erastin.html
Overall, a positive SR was observed in 23.6% of patients undergoing TESA. Average testis size (P = .017) and serum follicle-stimulating hormone (FSH) level (P .001) were the significant predictors of positive SR identified by LASSO regression analysis. The predictive model had an AUC of 0.742 with a sensitivity of 73.9% and specificity of 69.9%. Patients presenting with an average testis size 7.75 mL and serum FSH level 8.5 IU/L had a TESA-positive SR of 43%. TESA may be a suitable alternative to microTESE in selected nonob
Like
Comment
Share
